Skip to main content

J 267 J 267 (Mycophenolate Mofetil 250 mg)

Pill with imprint J 267 J 267 is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Jubilant Cadista Pharmaceuticals Inc.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for J 267 J 267

Mycophenolate Mofetil

Imprint
J 267 J 267
Strength
250 mg
Color
Blue & Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Jubilant Cadista Pharmaceuticals Inc.
National Drug Code (NDC)
59746-0267
Inactive Ingredients
croscarmellose sodium, magnesium stearate, povidone k90, corn starch, FD&C Blue No. 2, gelatin, ferric oxide red, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, shellac, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.